Iodixanol Injectable Solution

Iodixanol Injectable Solution

Form: Injectable Solution

Strength: 270 mg/mL, 320 mg/mL, 370 mg/mL

Reference Brands: Visipaque(US & EU)

Category: Contrast Agent

Iodixanol, marketed as Visipaque, is approved in the US by the FDA and in the EU via EMA for use as a contrast agent in X-ray and CT imaging procedures. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Supporting regional adherence supports swift approval, safe administration, and global availability of iodixanol, facilitating effective diagnostics worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Sulfur Hexafluoride Microbubbles injection

Strength: 60.7mg

Form: injection

Reference Brands: SonoVue(EU)

View Details Get Enquiry
Barium Sulfate Suspension

Strength: 30% w/v , 40% w/v

Form: Powder for oral suspension

Reference Brands: Gastroview, Osmo-Maq, FlexiView(US)

View Details Get Enquiry
Gadoxetate Injectable Solution

Strength: 0.25 mmol/mL

Form: Injectable Solution

Reference Brands: Eovist(US)

View Details Get Enquiry
Gadofosveset Injectable solution

Strength: 0.03 mmol/kg

Form: Injectable Solution

Reference Brands: Ablivar(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.